Stockreport

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update [Yahoo! Finance]

Vor Biopharma Inc.  (VOR) 
PDF In This Article VOR Vor Biopharma On-track for trem-cel + Mylotarg™ and VCAR33 ALLO clinical updates in the second half of 2024 CAMBRIDGE, Mass., Aug. 08, 2024 [Read more]